IBRX
Immunitybio Inc
NASDAQ: IBRX · HEALTHCARE · BIOTECHNOLOGY
$6.96
+0.00% today
Updated 2026-04-29
Market cap
$7.19B
P/E ratio
—
P/S ratio
63.45x
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$2 – $12
Volume
27.9M
Immunitybio Inc (IBRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |